Vertex (VRTX) PT Raised to $560 at Truist Securities Jul 13, 2026 07:42AM
Stifel Downgrades Crinetics (CRNX) to Hold Jul 8, 2026 08:45AM
H.C. Wainwright Reiterates Buy Rating on Vertex (VRTX) Jul 8, 2026 06:40AM
Jones Trading Downgrades Crinetics (CRNX) to Hold Jul 7, 2026 09:27AM
BMO Capital Reiterates Outperform Rating on Vertex (VRTX) Jul 7, 2026 08:49AM
View Older Stories

Jul 7, 2026 07:16AM Vertex (VRTX) Reiterated at Overweight by Cantor Fitzgerald; Crinetics Acquisition Announced
Jul 7, 2026 06:58AM Canaccord Reiterates Hold Rating on Vertex (VRTX)
Jul 7, 2026 05:44AM Vertex Pharma (VRTX) call put ratio 1 call to 1.8 puts into acquiring Crinetics
Jul 6, 2026 04:14PM Crinetics soars on $10B acquisition by Vertex
Jul 6, 2026 10:25AM Vertex signs LoI with the Pan-Canadian Pharmaceutical Alliance for alyftrek for the treatment of cystic fibrosis
Jul 1, 2026 05:43PM FDA approves Casgevy gene therapy for sickle cell in children 2+
Jun 12, 2026 02:42PM Leerink highlights drug demand rebound after Memorial Day
Jun 5, 2026 12:05PM Vertex presents positive data for ALYFTREK in young cystic fibrosis patients
Jun 1, 2026 08:01AM Vertex gets FDA acceptance for IgA nephropathy drug application
May 27, 2026 01:02AM Truist Securities Assumes Vertex (VRTX) at Buy
May 8, 2026 08:59AM BMO Capital Reiterates Market Perform Rating on Vertex (VRTX), 'positive steps'
May 6, 2026 07:01AM Vertex secures German reimbursement for CASGEVY gene therapy
May 5, 2026 09:26AM Cantor Fitzgerald Reiterates Overweight Rating on Vertex (VRTX) Post Q1 Print
May 5, 2026 07:50AM Vertex (VRTX) PT Lowered to $436 at Canaccord
May 5, 2026 06:06AM Oppenheimer Reiterates Outperform Rating on Vertex (VRTX)
May 5, 2026 05:59AM Vertex (VRTX) PT Lowered to $572 at Bernstein SocGen Group
May 4, 2026 04:03PM Vertex Pharma (VRTX) Tops Q1 EPS by 14c, Misses on Revenue; Offers FY26 Revenue Guidance
Apr 26, 2026 08:00PM U.S. Biotech stocks: Q1 earnings previews
Apr 23, 2026 06:58AM H.C. Wainwright Reiterates Buy Rating on Vertex (VRTX)
Apr 19, 2026 10:00AM These are the best biotech stocks to own in 2026: BofA
Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?
Apr 10, 2026 08:33AM Vertex (VRTX) PT Lowered to $541 at RBC Capital
Apr 7, 2026 08:05AM Halozyme licenses drug delivery technology to Vertex for $15 million
Mar 30, 2026 08:26AM BMO Capital on Vertex (VRTX): 'Ivacaftor Related Label Updates Unlikely to Impact CF Franchise Strength'
Mar 27, 2026 03:37PM BMO Capital on Vertex (VRTX): label updates weigh on shares, but risk is limited
Mar 21, 2026 01:55PM New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
Mar 19, 2026 08:55AM RBC Capital on Vertex (VRTX): 'Recent Weakness Creates Buying Opportunity'
Mar 19, 2026 05:27AM Vertex (VRTX) PT Raised to $520 at Argus
Mar 18, 2026 09:21AM RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
Mar 10, 2026 09:51AM Vertex (VRTX) PT Raised to $525 at Truist Securities
Mar 10, 2026 09:33AM Stifel Reiterates Hold Rating on Vertex (VRTX)
Mar 10, 2026 08:27AM Vertex (VRTX) PT Raised to $641 at H.C. Wainwright
Mar 10, 2026 08:02AM Bernstein: 'We continue to recommend Vertex (VRTX) and see no reason to take profits'
Mar 10, 2026 05:38AM Jefferies Starts Amgen (AMGN) at Hold
Mar 10, 2026 05:38AM Jefferies Starts Vertex (VRTX) at Buy
Mar 10, 2026 05:38AM Jefferies Starts Gilead Sciences (GILD) at Buy
Mar 10, 2026 05:09AM Vertex (VRTX) PT Raised to $600 at Oppenheimer
Mar 10, 2026 04:56AM Vertex (VRTX) PT Raised to $585 at Citi
Mar 9, 2026 05:35PM Wolfe Research Reiterates Outperform Rating on Vertex (VRTX) following Ph3
Mar 9, 2026 05:07PM BMO Capital Reiterates Outperform Rating on Vertex (VRTX) amid interim RAINIER data
Mar 9, 2026 04:44PM After-hours movers: Hewlett Packard Enterprise, Yext, Vertex Pharma
Mar 2, 2026 09:28AM Vertex (VRTX) PT Raised to $600 at BMO Capital
Feb 13, 2026 09:03AM Vertex (VRTX) PT Raised to $590 at Cantor Fitzgerald
Feb 13, 2026 06:43AM Oppenheimer Upgrades Vertex (VRTX) to Outperform
Feb 12, 2026 04:11PM Vertex Pharma (VRTX) Misses Q4 EPS by 5c; offers guidance
Feb 10, 2026 07:48AM Bernstein SocGen Group Reiterates Outperform Rating on Vertex (VRTX)
Jan 28, 2026 06:20AM Barclays Starts Vertex (VRTX) at Overweight, 'bullish into 2026 readouts'
Jan 23, 2026 04:44AM Vertex (VRTX) PT Raised to $530 at Evercore ISI
Jan 22, 2026 05:05AM RBC Capital Upgrades Vertex (VRTX) to Outperform
Jan 12, 2026 06:18AM Bernstein SocGen Group Upgrades Vertex (VRTX) to Outperform
View Older Stories